DNA Sequencing with Purification for Research at Chughtai Lab

DNA Sequencing with Purification for Research at Chughtai Lab

Molecular diagnostics and genomic research have revolutionized modern medicine, biotechnology, and life sciences. DNA Sequencing with Purification for Research at Chughtai Lab represents a premier, high-complexity laboratory service designed to meet the rigorous demands of academic researchers, clinical scientists, and biotechnologists across Pakistan. This specialized service combines state-of-the-art nucleic acid purification methodologies with high-throughput sequencing technologies to deliver exceptionally accurate, reproducible, and publication-ready genomic data. By utilizing advanced capillary electrophoresis and next-generation sequencing platforms, Chughtai Lab ensures that researchers receive high-quality sequence reads with optimal Phred quality scores, facilitating precise genetic analysis and downstream molecular applications.

The process of DNA sequencing begins with the critical step of template purification. Raw biological samples, PCR products, or plasmid vectors often contain inhibitory substances, such as residual salts, proteins, primers, and dNTPs, which can severely compromise the sequencing reaction. The purification phase of this service utilizes advanced spin-column chromatography or magnetic-bead-based technology to isolate high-purity DNA, free from enzymatic inhibitors and contaminants. Following purification, the DNA undergoes cycle sequencing using fluorescently labeled dideoxynucleoxytriphosphates (ddNTPs) in a modified polymerase chain reaction (PCR). The resulting extension fragments are separated by size using high-resolution capillary electrophoresis, and the emitted fluorescence is detected to generate a highly accurate chromatogram and sequence file. This comprehensive approach is vital for identifying genetic variations, verifying plasmid constructs, validating gene editing experiments, and advancing translational medical research.

Clinical Procedure: What to Expect

Patient and Sample Preparation

Because DNA Sequencing with Purification for Research at Chughtai Lab is primarily utilized for research, academic, and specialized diagnostic investigations, direct patient preparation is rarely required unless primary clinical specimens are being submitted. For researchers submitting pre-isolated DNA, PCR products, or plasmids, strict adherence to sample preparation guidelines is essential to ensure optimal sequencing outcomes:

• DNA Concentration and Purity: Submitted genomic DNA, plasmids, or PCR products must meet specific concentration thresholds (typically measured via spectrophotometry or fluorometry). The A260/A280 ratio should ideally fall between 1.8 and 2.0, indicating a clean sample free of protein contamination.
• Avoidance of Inhibitors: Samples must be dissolved in sterile, nuclease-free water or low-salt buffers (such as 10 mM Tris-HCl, pH 8.5). High concentrations of EDTA, salts, or ethanol from previous extraction steps must be avoided, as they inhibit DNA polymerase activity during cycle sequencing.
• Volume Requirements: A minimum volume of 15 to 20 microliters of the purified template is generally required, along with specific primers at designated concentrations if custom sequencing primers are being utilized.
• Labeling and Documentation: All sample tubes must be clearly labeled with unique identifiers matching the submission form, detailing the template type, estimated concentration, primer sequences, and expected product size.

During the Procedure

Once the samples are received at the molecular diagnostics division of Chughtai Lab, they undergo a systematic, quality-controlled laboratory workflow executed by experienced molecular biologists:

• Initial Quality Control (QC): The laboratory staff performs an initial assessment of the submitted samples using spectrophotometric analysis (e.g., NanoDrop) or fluorometric quantification (e.g., Qubit) to verify concentration and purity.
• Template Purification: If raw PCR products or unpurified plasmids are submitted, they undergo enzymatic purification (using ExoSAP-IT or similar reagents) or solid-phase extraction to remove unincorporated primers, nucleotides, and salts.
• Cycle Sequencing Reaction: The purified DNA template is mixed with the sequencing primer, DNA polymerase, dNTPs, and fluorescently labeled ddNTPs. The mixture is placed in a thermal cycler to undergo cycle sequencing, generating a pool of fragments of varying lengths, each terminated with a fluorescent dye.
• Post-Sequencing Clean-up: Unincorporated dye terminators are meticulously removed using gel filtration or magnetic bead separation to prevent “dye blobs” that can obscure the sequencing data.
• Capillary Electrophoresis: The purified sequencing products are loaded into an automated genetic analyzer. An electrical current pulls the DNA fragments through a polymer-filled capillary, separating them by size down to a single-nucleotide resolution. A laser excites the fluorescent dyes as they pass the detector, and the instrument records the light signals.
• Data Generation and Analysis: The raw fluorescent signals are converted by specialized software into a chromatogram (electropherogram) and a text file containing the nucleotide sequence (FASTA format), which is then reviewed by a molecular specialist for quality assurance.

When is DNA Sequencing with Purification for Research Performed?

Genetic Mutation Analysis and Variant Detection

Physicians, clinical trial investigators, and geneticists request this service to identify specific genetic mutations, single nucleotide polymorphisms (SNPs), insertions, or deletions within target genes. This is particularly crucial in hereditary disease research, where identifying a specific genetic variant can confirm a clinical diagnosis, guide family screening protocols, and contribute to global genetic databases. The purification step ensures that even low-abundance mutations are not masked by background noise or sequencing artifacts.

Pathogen Identification and Microbiome Studies

In infectious disease research and epidemiological studies, DNA sequencing is the gold standard for identifying bacterial, viral, fungal, or parasitic pathogens that are difficult to culture using traditional microbiological methods. By sequencing conserved regions, such as the 16S rRNA gene in bacteria or the Internal Transcribed Spacer (ITS) region in fungi, researchers can precisely identify species and strains. This assists in tracking outbreak dynamics, studying antimicrobial resistance profiles, and exploring the human microbiome’s role in health and disease.

Oncology Research and Biomarker Discovery

Oncologists and cancer researchers utilize DNA sequencing to detect somatic mutations, gene fusions, and copy number variations in tumor tissue or cell-free DNA (liquid biopsies). Identifying these genomic alterations is fundamental to the development of personalized medicine, allowing researchers to discover novel biomarkers, evaluate therapeutic efficacy, and understand the molecular mechanisms of drug resistance. High-purity sequencing is vital here to ensure the accurate detection of low-frequency subclonal mutations within heterogeneous tumor samples.

Evolutionary Biology and Phylogenetic Studies

Evolutionary biologists and taxonomists rely on DNA sequencing to study genetic diversity, phylogenetic relationships, and evolutionary history across various species. By sequencing specific mitochondrial or nuclear marker genes, researchers can construct phylogenetic trees, estimate divergence times, and map evolutionary pathways. The high sensitivity and accuracy of Chughtai Lab’s sequencing platform allow for the reliable analysis of diverse biological specimens, ranging from plant tissues to ancient or degraded DNA samples.

Gene Expression and Functional Genomics

In functional genomics, researchers study how genes and their products interact to influence cellular function. DNA sequencing is used to verify the sequence of cloned genes, plasmid vectors, and CRISPR-Cas9 gene-editing constructs before they are introduced into cell lines or model organisms. Ensuring 100% sequence fidelity through purification and sequencing prevents experimental failures caused by unwanted mutations or cloning errors, thereby safeguarding the integrity of academic and industrial research projects.

What Does DNA Sequencing with Purification for Research Detect?

DNA Sequencing with Purification for Research at Chughtai Lab is highly sensitive and capable of detecting a wide array of genetic, structural, and sequence-specific variations across diverse biological templates. Specifically, this advanced molecular technique detects:

• Single Nucleotide Polymorphisms (SNPs): Single-base changes in the DNA sequence that may be associated with disease susceptibility or drug metabolism.
• Point Mutations: Pathogenic or benign single-nucleotide alterations within coding or non-coding regions of a gene.
• Small Insertions and Deletions (Indels): The addition or loss of one or more nucleotides, which can cause frameshift mutations in protein-coding sequences.
• Frameshift Mutations: Genetic mutations caused by indels of a number of nucleotides not divisible by three, altering the translational reading frame.
• Missense Mutations: Single nucleotide changes that result in the substitution of one amino acid for another in the translated protein.
• Nonsense Mutations: Point mutations that introduce a premature stop codon, leading to truncated and often non-functional proteins.
• Synonymous (Silent) Mutations: Nucleotide changes that do not alter the amino acid sequence but may affect splicing or translation kinetics.
• Splice Site Variants: Mutations at intron-exon junctions that disrupt normal pre-mRNA splicing, leading to aberrant protein isoforms.
• Plasmid Vector Sequences: Verification of insert orientation, promoter regions, and cloning junctions in recombinant DNA constructs.
• PCR Amplification Fidelity: Detection of polymerase-induced errors introduced during PCR amplification of target genes.
• Bacterial Species and Strains: Identification of specific bacterial pathogens via 16S rRNA gene sequencing.
• Fungal Genotypes: Classification of fungal species using ITS region sequencing.
• Viral Mutational Profiles: Detection of drug-resistance mutations in viral genomes, such as HBV, HCV, or HIV.
• Gene Duplications: Presence of duplicated genetic segments that may contribute to overexpression or genetic instability.
• Chromosomal Translocations: Identification of fusion genes resulting from chromosomal rearrangements in research samples.
• Microsatellite Instability (MSI): Alterations in the length of repetitive DNA sequences, indicating DNA mismatch repair deficiency.
• Mitochondrial DNA (mtDNA) Mutations: Maternally inherited genetic variations associated with metabolic and neuromuscular disorders.
• Promoter and Regulatory Region Variants: Mutations in non-coding regions that control gene transcription and expression levels.
• CRISPR-Cas9 Off-Target Modifications: Verification of precise gene editing and detection of unintended genomic alterations.
• Antimicrobial Resistance (AMR) Genes: Presence of specific genetic determinants conferring resistance to antibiotics or antifungals.

Turnaround Time and Report Access at Chughtai Lab

Chughtai Lab is committed to providing timely, accurate, and accessible diagnostic and research services. The turnaround time (TAT) for DNA Sequencing with Purification for Research typically ranges from 5 to 7 business days, depending on the volume of samples submitted, the complexity of the sequencing requirements, and whether custom primers are utilized. Because research projects often operate on strict timelines, Chughtai Lab’s molecular diagnostics division works efficiently to minimize delays without compromising data quality.

Once the sequencing run is complete and has passed rigorous quality control checks, researchers can access their data through multiple convenient digital channels. Chughtai Lab offers an advanced online portal and a dedicated Mobile App, allowing users to download high-resolution chromatogram files (.ab1) and sequence text files (.seq or .fasta) securely from anywhere in Pakistan. Additionally, comprehensive PDF reports summarizing the sequencing quality, Phred scores, and contiguous read lengths can be sent directly via email or WhatsApp, ensuring seamless integration into the researcher’s workflow.

DNA Sequencing with Purification for Research Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal / Research Findings
Sequence Quality (Phred Score)	Average Phred score (Q) > 30 (99.9% base-calling accuracy) across the read.	Low Phred scores (Q < 20), indicating high background noise or poor template quality.
Contiguous Read Length (CRL)	Clean, readable sequence extending from 600 to 900 base pairs (for Sanger sequencing).	Premature termination of read, short CRL (< 300 bp) due to secondary structures or inhibitors.
Chromatogram Peak Resolution	Sharp, well-defined, single-colored peaks with minimal baseline noise.	Overlapping peaks, double peaks (indicating heterozygosity or mixed templates), or high baseline noise.
Gene Sequence Alignment	100% homology with the reference wild-type genomic sequence.	Presence of point mutations, SNPs, insertions, deletions, or gene rearrangements.
Plasmid Insert Integrity	Exact match with the designed recombinant plasmid map, correct orientation.	Absence of insert, reverse orientation, or point mutations within the promoter/coding region.
Pathogen Identification	No pathogenic DNA detected (in sterile control samples).	Detection of specific bacterial, viral, or fungal DNA sequences matching reference databases.
Primer Binding Site	Intact, fully complementary sequence matching the designed sequencing primer.	Mutations or deletions at the primer binding site, preventing successful hybridization and sequencing.

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Chughtai Lab for DNA Sequencing with Purification for Research?

• Experienced Healthcare Professionals: Our molecular biology division is staffed by highly trained geneticists, pathologists, and laboratory technologists with extensive experience in genomic sequencing.
• Patient-Focused Care: We prioritize the specific needs of clinical researchers and patients, offering tailored support throughout the sample submission and analysis process.
• Quality Diagnostic Services: Chughtai Lab adheres to international quality standards, participating in rigorous external quality assurance and proficiency testing programs.
• Professional Reporting: We deliver comprehensive, easy-to-interpret sequencing reports alongside raw data files (.ab1 and .fasta) for complete scientific transparency.
• Modern Diagnostic Approach: Utilizing state-of-the-art automated genetic analyzers and advanced purification chemistry ensures unmatched accuracy and reproducibility.
• Comfortable Environment: With a vast network of collection centers across Pakistan, submitting research samples is convenient, safe, and professional.
• Convenient Location: Our primary molecular reference laboratory is centrally located, supported by hundreds of express centers nationwide for easy sample drop-off.
• Commitment to Accurate Diagnosis: We are dedicated to advancing medical research in Pakistan by providing reliable, high-quality genomic data that drives scientific discovery.